Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

High-Dose Therapy Treatment in Patients With Follicular Lymphoma

This study has been completed.
Sponsor:
Information provided by:
French Innovative Leukemia Organisation
ClinicalTrials.gov Identifier:
NCT00696735
First received: June 11, 2008
Last updated: October 23, 2008
Last verified: September 2006